Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Springworks Therapeutics, Inc. (SWTX) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Springworks Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1773427.
Total stock buying since 2019: $14,400,000.
Total stock sales since 2019: $408,122,556.
Total stock option exercises since 2019: $1,904,668.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 454,540 | $25,243,495 | 43,524 | $1,266,776 |
| 2024 | 0 | $0 | 221,237 | $9,281,424 | 16,250 | $449,150 |
| 2023 | 0 | $0 | 1,756,782 | $50,071,918 | 0 | $0 |
| 2022 | 0 | $0 | 274,568 | $10,464,362 | 0 | $0 |
| 2021 | 0 | $0 | 4,164,498 | $313,061,357 | 42,320 | $188,742 |
| 2019 | 800,000 | $14,400,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-03 | 0 | $0 | 69,000 | $3,792,342 | 0 | $0 |
| 2025-02 | 0 | $0 | 385,540 | $21,451,153 | 43,524 | $1,266,776 |
| 2024-12 | 0 | $0 | 69,000 | $2,878,199 | 0 | $0 |
| 2024-09 | 0 | $0 | 69,000 | $2,835,547 | 0 | $0 |
| 2024-06 | 0 | $0 | 49,000 | $2,002,385 | 0 | $0 |
| 2024-02 | 0 | $0 | 34,237 | $1,565,293 | 16,250 | $449,150 |
| 2023-07 | 0 | $0 | 2,418 | $70,876 | 0 | $0 |
| 2023-06 | 0 | $0 | 2,400 | $64,603 | 0 | $0 |
| 2023-03 | 0 | $0 | 1,751,106 | $49,909,841 | 0 | $0 |
| 2023-01 | 0 | $0 | 858 | $26,598 | 0 | $0 |
| 2022-08 | 0 | $0 | 274,568 | $10,464,362 | 0 | $0 |
| 2021-10 | 0 | $0 | 72,500 | $4,225,570 | 10,000 | $23,000 |
| 2021-09 | 0 | $0 | 0 | $0 | 2,320 | $99,992 |
| 2021-08 | 0 | $0 | 1,000,000 | $70,250,000 | 0 | $0 |
| 2021-07 | 0 | $0 | 88,459 | $6,950,638 | 10,000 | $23,000 |
| 2021-06 | 0 | $0 | 135,539 | $11,551,643 | 0 | $0 |
| 2021-04 | 0 | $0 | 93,500 | $6,530,013 | 10,000 | $23,000 |
| 2021-03 | 0 | $0 | 2,670,000 | $205,166,800 | 0 | $0 |
| 2021-01 | 0 | $0 | 104,500 | $8,386,693 | 10,000 | $19,750 |
| 2019-09 | 800,000 | $14,400,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-03 | Edris Badreddin (Chief Operating Officer) | Sale | 20,000 | 54.68 | 1,093,520 |
| 2025-03-03 | Islam Saqib (Chief Executive Officer) | Sale | 49,000 | 55.08 | 2,698,822 |
| 2025-02-20 | Ashar Bhavesh (Chief Commercial Officer) | Sale | 1,016 | 61.19 | 62,168 |
| 2025-02-20 | Islam Saqib (Chief Executive Officer) | Sale | 29,328 | 60.67 | 1,779,300 |
| 2025-02-20 | Lynch Daniel | Sale | 47,600 | 60.69 | 2,888,748 |
| 2025-02-14 | Islam Saqib (Chief Executive Officer) | Sale | 10,672 | 59.92 | 639,487 |
| 2025-02-14 | Lynch Daniel | Sale | 400 | 60.00 | 24,000 |
| 2025-02-10 | Pichl Daniel (Chief People Officer) | Sale | 29,750 | 54.81 | 1,630,508 |
| 2025-02-10 | Pichl Daniel (Chief People Officer) | Option Ex | 29,750 | 27.64 | 822,290 |
| 2025-02-10 | Edris Badreddin (Chief Operating Officer) | Sale | 30,000 | 53.13 | 1,593,810 |
| 2025-02-10 | Hambleton Julie | Sale | 13,774 | 53.01 | 730,201 |
| 2025-02-10 | Hambleton Julie | Option Ex | 13,774 | 32.27 | 444,486 |
| 2025-02-10 | Islam Saqib (Chief Executive Officer) | Sale | 48,000 | 53.30 | 2,558,256 |
| 2025-02-10 | Lynch Daniel | Sale | 175,000 | 54.54 | 9,544,675 |
| 2024-12-03 | Edris Badreddin (Chief Operating Officer) | Sale | 20,000 | 42.01 | 840,240 |
| 2024-12-02 | Islam Saqib (Chief Executive Officer) | Sale | 49,000 | 41.59 | 2,037,959 |
| 2024-09-03 | Edris Badreddin (Chief Operating Officer) | Sale | 20,000 | 41.10 | 822,039 |
| 2024-09-03 | Islam Saqib (Chief Executive Officer) | Sale | 49,000 | 41.09 | 2,013,508 |
| 2024-06-03 | Islam Saqib (Chief Executive Officer) | Sale | 49,000 | 40.87 | 2,002,385 |
| 2024-02-05 | Ashar Bhavesh (Chief Commercial Officer) | Sale | 4,834 | 49.33 | 238,437 |
| 2024-02-02 | Ashar Bhavesh (Chief Commercial Officer) | Sale | 3,222 | 45.11 | 145,334 |
| 2024-02-02 | Pichl Daniel (Chief People Officer) | Sale | 26,181 | 45.13 | 1,181,522 |
| 2024-02-02 | Pichl Daniel (Chief People Officer) | Option Ex | 16,250 | 27.64 | 449,150 |
| 2023-07-19 | Hambleton Julie | Sale | 2,418 | 29.31 | 70,876 |
| 2023-06-20 | Hambleton Julie | Sale | 2,400 | 26.92 | 64,603 |
| 2023-03-16 | Schwartz Jeffrey Lawrence (Director) | Sale | 1,750,000 | 28.50 | 49,875,000 |
| 2023-03-15 | Hambleton Julie | Sale | 1,106 | 31.50 | 34,841 |
| 2023-01-26 | Pichl Daniel (Chief People Officer) | Sale | 858 | 31.00 | 26,598 |
| 2022-08-09 | Orbimed Capital Gp Vi Llc | Sale | 69,568 | 37.47 | 2,606,712 |
| 2022-08-08 | Orbimed Capital Gp Vi Llc | Sale | 205,000 | 38.33 | 7,857,650 |
| 2021-10-20 | Islam Saqib (Chief Executive Officer) | Sale | 10,083 | 58.67 | 591,529 |
| 2021-10-19 | Islam Saqib (Chief Executive Officer) | Sale | 14,077 | 58.81 | 827,868 |
| 2021-10-18 | Islam Saqib (Chief Executive Officer) | Sale | 38,340 | 58.59 | 2,246,493 |
| 2021-10-13 | Smith L. Mary (Chief Development Officer) | Sale | 10,000 | 55.97 | 559,680 |
| 2021-10-13 | Smith L. Mary (Chief Development Officer) | Option Ex | 10,000 | 2.30 | 23,000 |
| 2021-09-08 | Pichl Daniel (Chief People Officer) | Option Ex | 2,320 | 43.10 | 99,992 |
| 2021-08-10 | Koppel Adam (10% Owner) | Sale | 1,000,000 | 70.25 | 70,250,000 |
| 2021-07-20 | Islam Saqib (Chief Executive Officer) | Sale | 18,572 | 77.68 | 1,442,747 |
| 2021-07-19 | Islam Saqib (Chief Executive Officer) | Sale | 43,928 | 76.09 | 3,342,437 |
| 2021-07-13 | Smith L. Mary (Chief Development Officer) | Sale | 10,000 | 80.88 | 808,780 |
| 2021-07-13 | Smith L. Mary (Chief Development Officer) | Option Ex | 10,000 | 2.30 | 23,000 |
| 2021-07-01 | Orbimed Capital Gp Vi Llc | Sale | 15,959 | 85.01 | 1,356,674 |
| 2021-06-25 | Orbimed Capital Gp Vi Llc | Sale | 22,334 | 85.14 | 1,901,516 |
| 2021-06-24 | Orbimed Capital Gp Vi Llc | Sale | 34,200 | 85.22 | 2,914,524 |
| 2021-06-23 | Orbimed Capital Gp Vi Llc | Sale | 100 | 85.00 | 8,500 |
| 2021-06-10 | Orbimed Capital Gp Vi Llc | Sale | 30,852 | 85.09 | 2,625,196 |
| 2021-06-09 | Orbimed Capital Gp Vi Llc | Sale | 5,049 | 85.33 | 430,831 |
| 2021-06-08 | Orbimed Capital Gp Vi Llc | Sale | 42,633 | 85.37 | 3,639,579 |
| 2021-06-07 | Orbimed Capital Gp Vi Llc | Sale | 371 | 84.90 | 31,497 |
| 2021-04-28 | Squinto Stephen P | Sale | 19,231 | 76.20 | 1,465,440 |
| 2021-04-27 | Squinto Stephen P | Sale | 201 | 75.05 | 15,085 |
| 2021-04-20 | Islam Saqib (Chief Executive Officer) | Sale | 24,075 | 66.39 | 1,598,291 |
| 2021-04-19 | Islam Saqib (Chief Executive Officer) | Sale | 38,425 | 69.04 | 2,652,823 |
| 2021-04-15 | Squinto Stephen P | Sale | 1,057 | 75.02 | 79,290 |
| 2021-04-14 | Squinto Stephen P | Sale | 511 | 75.08 | 38,364 |
| 2021-04-13 | Smith L. Mary (Chief Development Officer) | Sale | 10,000 | 68.07 | 680,720 |
| 2021-04-13 | Smith L. Mary (Chief Development Officer) | Option Ex | 10,000 | 2.30 | 23,000 |
| 2021-03-09 | Koppel Adam (10% Owner) | Sale | 1,450,000 | 71.50 | 103,675,000 |
| 2021-03-01 | Orbimed Capital Gp Vi Llc | Sale | 1,220,000 | 83.19 | 101,491,800 |
| 2021-01-25 | Edris Badreddin (Chief Operating Officer) | Sale | 32,000 | 84.07 | 2,690,272 |
| 2021-01-20 | Smith L. Mary (Chief Development Officer) | Sale | 10,000 | 78.70 | 787,020 |
| 2021-01-20 | Smith L. Mary (Chief Development Officer) | Option Ex | 10,000 | 1.98 | 19,750 |
| 2021-01-20 | Islam Saqib (Chief Executive Officer) | Sale | 2,199 | 78.75 | 173,180 |
| 2021-01-19 | Islam Saqib (Chief Executive Officer) | Sale | 60,301 | 78.54 | 4,736,221 |
| 2019-09-17 | Pfizer Ventures (us) Llc (10% Owner) | Buy | 50,000 | 18.00 | 900,000 |
| 2019-09-17 | Orbimed Capital Gp Vi Llc | Buy | 275,000 | 18.00 | 4,950,000 |
| 2019-09-17 | Koppel Adam (10% Owner) | Buy | 150,000 | 18.00 | 2,700,000 |
| 2019-09-17 | Lewis-hall Freda C | Buy | 50,000 | 18.00 | 900,000 |
| 2019-09-17 | Squinto Stephen P | Buy | 275,000 | 18.00 | 4,950,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SWTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Springworks Therapeutics, Inc. (symbol SWTX, CIK number 1773427) see the Securities and Exchange Commission (SEC) website.